Cancer patients can now be ‘matched’ to best treatment with DNA and lab-dish experiments
Today Headline,
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
Cancer patients are also getting younger. Cancer diagnoses among those under 50 has risen by about 80% worldwide over the past…
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
The next innovation in cancer treatment could be to test all possible drugs on thousands of miniature versions of a person’s…
Identifying the most effective cancer treatment for a given patient from the get-go can help improve outcomes.
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Diana Azzam…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Diana Azzam…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Diana Azzam…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Diana Azzam…
By Diana Azzam, Florida International University (The Conversation is an independent and nonprofit source of news, analysis and…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Diana Azzam…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Diana Azzam…
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among…
The "try-everything tactic" appears to bring meaningful improvements in some cancer patients, but the approach comes with…
AI-tekniken har stor potential inom cancervården och den används framgångsrikt redan i dag – både i Finland och utomlands.
This article is the fifth in our "Trends in digital health" series. The next article, "Health apps as software medical devices…
At 82 years old, with an aggressive form of blood cancer that six courses of chemotherapy had failed to eliminate, “Paul…
US Markets Loading... H M S Premium AstraZeneca This story is available exclusively to Insider subscribers.
The single-cell functional precision medicine treatment, an artificial intelligence strategy helps to create therapies for…
A precision medicine approach proved clinically feasible and effective for patients with advanced hematologic cancers…
Im Onko-Blog dieser Woche geht es um 2 neue Leitlinien: Die ESMO hat die Leitlinie zum metastasierten Mammakarzinom aktualisiert…
Standard therapy for advanced recurring aggressive, hematological malignancies, such as leukemias and lymphomas, have a limited…
Standard therapy for advanced recurring aggressive, haematological malignancies, such as leukemias and lymphomas, have a…
Standard therapy for advanced recurring aggressive, hematological malignancies, such as leukemias and lymphomas, have a limited…
Standard therapy for advanced recurring aggressive, hematological malignancies, such as leukemias and lymphomas, have a limited…
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Standard therapy for advanced recurring…
Figure S1. Sunburst plot showing the classes of drugs tested by scFPM. Drugs can be broadly classified into kinase inhibitors…
Aggressive, hämatologische Krebserkrankungen wie Leukämien oder Lymphome sind im fortgeschrittenen, wiederkehrenden Stadium nur…
Standard therapy for advanced recurring aggressive, hematological malignancies, such as leukemias and lymphomas, have a limited…
Standard therapy for advanced recurring aggressive, hematological malignancies, such as leukemias and lymphomas, have a limited…
Personalisierte Medizin wird vor allem in der Krebstherapie immer wichtiger, weil Behandlungen bei Betroffenen mit gleichem…
Personalisierte Medizin wird vor allem in der Krebstherapie immer wichtiger, weil Behandlungen bei Betroffenen mit gleichem…